ipsogen — a wide range of oncohematology assays


Ensuring accuracy in blood cancer molecular testing
Using genomic biomarkers enables diagnosis, prognosis, and follow-up of patients suffering from cancer. QIAGEN’s ipsogen portfolio provides a wide range of CE-IVD marked oncohematology diagnostic assays for determining an individual’s biomarker status.

kits provide:
  • Sensitive qualitative and quantitative assays
  • Standardized assays for reproducible results
  • Accurate EAC technology for gene transcripts
  • Quality control ISO 13485 certification
  • Ease of use with the Rotor-Gene Q instrument